
Japan's Solasia Pharma licenses DARVIAS and Episil to Firebird for 19 countries
Under the terms of the agreement, a licensing deal has been established to facilitate the commercialisation and marketing of products in the territories of Asia including Australia & New Zealand, the Middle East, and Africa by Firebird Biologics. …